Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Rikhia, Chakraborty"'
Autor:
Jared Ehrhart, Seth Currlin, Angie Rivera, Michelle Ataya, Jasmin D’Andrea, Alliyah Humphrey, Rikhia Chakraborty, Soner Altoik
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/0c8c1d469f014b859526a7c5c7cb1a98
Autor:
Jared Ehrhart, Seth Currlin, Angie Rivera, Michelle Ataya, Jasmin D’Andrea, Alliyah Humphrey, Rikhia Chakraborty, Soner Altoik
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/92bdfe2a80ad43dc88b6e800f238d974
Autor:
Karen Phaik Har Lim, Paul Milne, Michael Poidinger, Kaibo Duan, Howard Lin, Naomi McGovern, Harshal Abhyankar, Daniel Zinn, Thomas M. Burke, Olive S. Eckstein, Rikhia Chakraborty, Amel Sengal, Brooks Scull, Evan Newell, Miriam Merad, Kenneth L. McClain, Tsz-Kwong Man, Florent Ginhoux, Matthew Collin, Carl E. Allen
Publikováno v:
Blood Advances, Vol 4, Iss 1, Pp 87-99 (2020)
Abstract: Langerhans cell histiocytosis (LCH) is a myeloproliferative disorder that is characterized by the inflammatory lesions with pathogenic CD1a+CD207+ dendritic cells (DCs). BRAFV600E and other somatic activating MAPK gene mutations have been i
Externí odkaz:
https://doaj.org/article/c86f478e226541b0bac33e2a435850d6
Autor:
Sébastien Héritier, Zofia Hélias-Rodzewicz, Rikhia Chakraborty, Amel G. Sengal, Christine Bellanné-Chantelot, Caroline Thomas, Anne Moreau, Sylvie Fraitag, Carl E. Allen, Jean Donadieu, Jean-François Emile
Publikováno v:
Molecular Cancer, Vol 16, Iss 1, Pp 1-5 (2017)
Abstract Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplasia with constitutive activation of the MAPKinase RAS-RAF-MEK-ERK cell signaling pathway. We analyzed 9 LCH cases without BRAF V600 and MAP2K1 mutations by whole exome sequ
Externí odkaz:
https://doaj.org/article/5fcf34ebe17645f294020d25a4adfd9c
Autor:
Paul Milne, Harshal Abhyankar, Brooks Scull, Preeti Singh, Rikhia Chakraborty, Carl E. Allen, Matthew Collin
Publikováno v:
Blood Advances. 6:4901-4904
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eec0c98e31b0198f706688b2793f5cc9
https://doi.org/10.1182/bloodadvances.2022007519
https://doi.org/10.1182/bloodadvances.2022007519
Autor:
Eveline Barbieri, Jason M. Shohet, Silke Paust, Eugene S. Kim, Vivien Sheehan, Sanjeev A. Vasudevan, Jan J. Molenaar, Rikhia Chakraborty, Yankai Zhang, Rana Nikzad, Kevin Aviles-Padilla, Linda Schild, Kathleen A. Scorsone, Ling Tao, Zaowen Chen, Anna Lakoma, Myrthala Moreno-Smith
Survivin protein determination in multiple neuroblastoma lines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::324b38f5884525187183b05cbff54dee
https://doi.org/10.1158/1078-0432.22468167
https://doi.org/10.1158/1078-0432.22468167
Autor:
Eveline Barbieri, Jason M. Shohet, Silke Paust, Eugene S. Kim, Vivien Sheehan, Sanjeev A. Vasudevan, Jan J. Molenaar, Rikhia Chakraborty, Yankai Zhang, Rana Nikzad, Kevin Aviles-Padilla, Linda Schild, Kathleen A. Scorsone, Ling Tao, Zaowen Chen, Anna Lakoma, Myrthala Moreno-Smith
Purpose: mTORC1 inhibitors are promising agents for neuroblastoma therapy; however, they have shown limited clinical activity as monotherapy, thus rational drug combinations need to be explored to improve efficacy. Importantly, neuroblastoma maintain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31e1854cdfe0feda0db08be80b004f1e
https://doi.org/10.1158/1078-0432.c.6526860
https://doi.org/10.1158/1078-0432.c.6526860
Autor:
Eveline Barbieri, Jason M. Shohet, Silke Paust, Eugene S. Kim, Vivien Sheehan, Sanjeev A. Vasudevan, Jan J. Molenaar, Rikhia Chakraborty, Yankai Zhang, Rana Nikzad, Kevin Aviles-Padilla, Linda Schild, Kathleen A. Scorsone, Ling Tao, Zaowen Chen, Anna Lakoma, Myrthala Moreno-Smith
Effect of combined RG7388 and temsirolimus on human PBMCs viability and apoptosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56b91f4594eef27eb72c162cabdfebfd
https://doi.org/10.1158/1078-0432.22468182
https://doi.org/10.1158/1078-0432.22468182
Autor:
Eveline Barbieri, Jason M. Shohet, Silke Paust, Eugene S. Kim, Vivien Sheehan, Sanjeev A. Vasudevan, Jan J. Molenaar, Rikhia Chakraborty, Yankai Zhang, Rana Nikzad, Kevin Aviles-Padilla, Linda Schild, Kathleen A. Scorsone, Ling Tao, Zaowen Chen, Anna Lakoma, Myrthala Moreno-Smith
Supplementary Material and Figures "clean"
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3316a008f8958910d7a9e83d1d1d5d34
https://doi.org/10.1158/1078-0432.22468164.v1
https://doi.org/10.1158/1078-0432.22468164.v1
Autor:
Eveline Barbieri, Jason M. Shohet, Silke Paust, Eugene S. Kim, Vivien Sheehan, Sanjeev A. Vasudevan, Jan J. Molenaar, Rikhia Chakraborty, Yankai Zhang, Rana Nikzad, Kevin Aviles-Padilla, Linda Schild, Kathleen A. Scorsone, Ling Tao, Zaowen Chen, Anna Lakoma, Myrthala Moreno-Smith
Temsirolimus blocks in vivo tumor growth by suppressing mTOR activity.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbebd0d26309c1525607c6b3039acc9c
https://doi.org/10.1158/1078-0432.22468191
https://doi.org/10.1158/1078-0432.22468191